IP Library Granted Patent US 8,369,956
Granted Patent B2
US 8,369,956 · App. 13/214,077 · Granted Feb 5, 2013

Neurostimulator

Inventors: Bruce C. Towe (Mesa, AZ); William E. Crisp (Paradise Valley, AZ)
Assignee: Arizona Board of Regents, a Body Corporate, Acting for and on behalf of Arizona State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,369,956
App. No.
13/214,077
Granted
Feb 5, 2013
Kind
B2
Abstract

Methods and devices for stimulating nerves are disclosed. In one embodiment adapted for stimulating excitable tissue, the invention includes drive circuitry, an acoustic transducer and a pair of electrodes.

Claims (44)

1. A neurostimulator, comprising:

drive circuitry;

an acoustic transducer connected to the drive circuitry; and

an implantable stimulator having a piezoelectric chip and a pair of electrodes;

where the drive circuitry is configured to drive the acoustic transducer to generate a pressure wave;

where the acoustic transducer is positioned to direct the pressure wave at the implantable stimulator and generate a current between the pair of electrodes;

where the piezoelectric chip comprises

a piezoelectric element having at least two opposite surfaces;

a diode; and

a biocompatible coating surrounding the piezoelectric element and the diode.

2. The neurostimulator of claim 1 , wherein the piezoelectric chip includes lead zirconate titanate (PZT).

3. The neurostimulator of claim 1 , where in the piezoelectric chip includes polyvinylidene fluoride (PVDF).

4. The neurostimulator of claim 1 , wherein the drive circuitry further comprises:

a pulse generator;

a function generator connected to the pulse generator; and

amplifier circuitry connected to the function generator.

5. The neurostimulator of claim 4 , wherein the amplifier circuitry comprises:

a drive amplifier; and

a RF amplifier.

6. A neurostimulator, comprising:

drive circuitry;

an acoustic transducer connected to the drive circuitry; and

an implantable stimulator having a piezoelectric chip and a pair of electrodes;

where the drive circuitry is configured to drive the acoustic transducer to generate a pressure wave;

where the acoustic transducer is positioned to direct the pressure wave at the implantable stimulator and generate a current between the pair of electrodes; and

further comprising additional piezoelectric chips,

where each of the piezoelectric chips has a different resonant frequency; and

where the drive circuitry is configured to drive the acoustic transducer at the resonant frequency of one of the piezoelectric chips.

7. A method of stimulating tissue, comprising:

applying high frequency ultrasound signals to body tissue;

applying electrical stimulation to the body tissue using a pair of electrodes; and

where the high frequency ultrasound signal inhibits the generation of a compound action potential in a nerve fiber.

8. The method of claim 7 , where the electrodes are located external to a subject.

9. The method of claim 7 , where the electrodes are internal to a subject and where applying electrical stimulation to the body tissue using a pair of electrodes comprises:

producing drive electrical signals in a drive circuitry;

emitting pressure waves with an acoustic transducer in response to the drive electrical signals; and

converting the pressure waves into stimulation electrical signals in an implantable stimulator, where the implantable stimulator includes a piezoelectric chip and a pair of electrodes.

10. The method of claim 9 , where one of the drive electrical signals is a pulse.

11. The method of claim 9 , where the high-frequency ultrasound signal occurs before converting the pressure waves into stimulation electrical signals.

12. The method of claim 9 , where the high frequency ultrasound signal is a pulse having a length of between 300 μs and 10 ms.

13. The method of claim 9 , where the high frequency ultrasound signal is a series of pulses with a repetition rate between 1 pulse per second and 10 pulses per second.

14. The method of claim 9 , where the implantable stimulator is placed in close proximity to a nerve in a patient.

15. The method of claim 7 , where the high frequency ultrasound signal provides stimulation to a tissue.

16. The method of claim 7 , further comprising stimulating a pudental nerve with the electrical stimulation.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 7, 2019
From: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 049994/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2013
From: TOWE, BRUCE; CRISP, WILLIAM E.
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 031278/0117 →
CONFIRMATORY LICENSE Recorded May 29, 2013
From: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030502/0312 →
Continuity (5)
Continuation 12732001 · Mar 25, 2010
Continuation 10524955
Provisional Application 60404697 · Aug 19, 2002
Provisional Application 60473240 · May 23, 2003
Related Publication 20120041499A1 · Feb 16, 2012